Search research articles
Contact Us
Filters
Showing results (81-90 of 134) with videos related to
Page
of 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia
William Blum, Rebecca B Klisovic, Bjoern Hackanson, et al.
Blood
|
May 15, 2015
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
Ta-Ming Liu, Jennifer A Woyach, Yiming Zhong, et al.
Blood
|
January 14, 2011
Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma
Lapo Alinari, Bo Yu, Beth A Christian, et al.
Blood
|
May 13, 2010
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M Benson, Courtney E Bakan, Anjali Mishra, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansion
Jennifer Yeung, Sophia Y Philbrook, Emma Uible, et al.
Cancer
|
March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival
Jonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2008
Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia
Leslie A Andritsos, Amy J Johnson, Gerard Lozanski, et al.
British Journal of Haematology
|
April 21, 2015
Jumping translocations, a novel finding in chronic lymphocytic leukaemia
Cecelia R Miller, Deborah Stephens, Amy S Ruppert, et al.
Mabs
|
July 26, 2013
Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies
Sarwish Rafiq, Anthony Siadak, Jonathan P Butchar, et al.
Leukemia & Lymphoma
|
September 13, 2014
A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphoma
Craig C Hofmeister, Nita Williams, Susan Geyer, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 134) with videos related to
Sort By:
Page
of 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia
William Blum, Rebecca B Klisovic, Bjoern Hackanson, et al.
Blood
|
May 15, 2015
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
Ta-Ming Liu, Jennifer A Woyach, Yiming Zhong, et al.
Blood
|
January 14, 2011
Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma
Lapo Alinari, Bo Yu, Beth A Christian, et al.
Blood
|
May 13, 2010
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M Benson, Courtney E Bakan, Anjali Mishra, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansion
Jennifer Yeung, Sophia Y Philbrook, Emma Uible, et al.
Cancer
|
March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival
Jonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2008
Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia
Leslie A Andritsos, Amy J Johnson, Gerard Lozanski, et al.
British Journal of Haematology
|
April 21, 2015
Jumping translocations, a novel finding in chronic lymphocytic leukaemia
Cecelia R Miller, Deborah Stephens, Amy S Ruppert, et al.
Mabs
|
July 26, 2013
Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies
Sarwish Rafiq, Anthony Siadak, Jonathan P Butchar, et al.
Leukemia & Lymphoma
|
September 13, 2014
A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphoma
Craig C Hofmeister, Nita Williams, Susan Geyer, et al.
Page
of 14